Related Experiment Video
Updated: May 18, 2026
09:57
A Protocol to Set Up Needle-Free Connector with Positive Displacement on Central Venous Catheter in Intensive Care Unit
Published on: July 13, 2019
Evaluation of safe infusion devices for antineoplastic administration
Laure Lalande1, Guillaume Galy, Emilie Dussossoy
1Department of Pharmacy, Hôpital Edouard Herriot, Hospices Civils de Lyon, Lyon, France. laure.lalande@chu-lyon.fr
Summary
New cytotoxic safe infusion systems (CSISs) were evaluated for nurses
Area of Science:
- Oncology
- Occupational Health
- Medical Device Technology
Background:
- Nurses face daily low-level exposure to cytotoxic drugs, posing risks of significant absorption and potential adverse health effects.
- Cytotoxic drugs are essential in cancer treatment but require careful handling due to their inherent toxicity.
Purpose of the Study:
- To evaluate the efficacy of novel cytotoxic safe infusion systems (CSISs) in reducing occupational exposure for nurses.
- To assess the impact of CSISs on the quality of cytotoxic drug administration.
- To analyze the economic implications of implementing CSISs in clinical settings.
Main Methods:
- A comparative study was conducted in two cancer units.
- Cytotoxic safe infusion systems (CSISs) from three different manufacturers were tested.
- CSISs were compared against standard infusion sets used for cytotoxic drug delivery.
Main Results:
- Results indicate that CSISs may offer improved safety profiles compared to traditional methods.
- The study provides data on the effectiveness of CSISs in minimizing nurse exposure.
- Performance variations between different CSIS manufacturers were observed.
Conclusions:
- Cytotoxic safe infusion systems (CSISs) show potential for enhancing nurse safety during chemotherapy administration.
- Further research is warranted to optimize CSIS technology and confirm long-term benefits.
- The integration of CSISs may represent a significant advancement in healthcare worker protection within oncology settings.
Related Concept Videos
01:28Parenteral Drug Delivery Systems: Injectables, Implants, and Infusion Devices
Parenteral drug delivery systems play a crucial role in modern therapeutics by enabling the direct administration of drugs into the systemic circulation, bypassing the gastrointestinal tract. These systems are particularly valuable for poorly absorbed oral medications that are unstable in the digestive environment or require rapid onset or sustained therapeutic levels. Delivery is achieved through intravenous, intramuscular, or subcutaneous routes, each selected based on the drug's properties...
01:24Drug Accumulation During Multiple Dosing: Intermittent IV Infusions
Intermittent intravenous (IV) infusion is a method of drug administration where medications are delivered over short infusion periods followed by intervals of no drug delivery. This approach helps to prevent sustained high drug concentrations in the bloodstream, reducing the risk of adverse effects associated with prolonged exposure. Unlike continuous infusion, steady-state concentrations may not be achieved during a single dosing cycle but can be reached through repeated...
01:15Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations
Gentamicin, an aminoglycoside antibiotic, is commonly administered via intermittent intravenous infusion to treat severe infections. An intermittent one-hour infusion of gentamicin, administered at eight-hour intervals, allows for precise control of plasma drug concentrations, minimizing toxicity while ensuring therapeutic efficacy. Pharmacokinetic principles govern the dynamics of plasma concentrations and can be mathematically described using specific equations.The plasma drug concentration...
01:19One-Compartment Open Model for IV Bolus Administration: General Considerations
The one-compartment model is a pharmacokinetic tool that models the body as a single, uniform compartment, facilitating the understanding of drug distribution and elimination. This model is particularly beneficial for intravenous (IV) bolus administration, where the drug rapidly circulates throughout the body.
The drug's presence in the body is defined by an equation representing the difference between the rates of drug entry and exit. Key parameters—elimination rate constant, half-life,...
The drug's presence in the body is defined by an equation representing the difference between the rates of drug entry and exit. Key parameters—elimination rate constant, half-life,...
01:28IV Infusion to Oral Dosing: Conversion Methods
The development of extended-release formulations has facilitated the transition from intravenous to oral medication, offering a more convenient and patient-friendly approach to drug administration. This transition, however, requires careful management to ensure that therapeutic drug levels are maintained, preserving efficacy and avoiding adverse effects. Understanding pharmacokinetic principles and dosage calculations is critical during this process.Pharmacokinetics of the...